Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Therapix Biosciences Ltd ADR TRPXY

Therapix Biosciences Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several innovative immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The operating segments of the group are Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the Company's operation); and Pain clinic


OTCPK:TRPXY - Post by User

Comment by Fundy13on Mar 27, 2019 1:30pm
54 Views
Post# 29543468

RE:6K 03/26 Not good

RE:6K 03/26 Not goodI do not see that as being very important.
This stock comes down to one thing.  Do they find a buyer or not.
The research they have done is easily worth more than the current market cap, however they do not have the money to continue the research.  So they either find a buyer which will likely be at a higher share price, or they do not and have to raise money likey by issuing more shares which would cause the price to fall.
Either way they have to come up with a solution soon, because the bank account will be a zero  in 1-2 months I am guessing.
<< Previous
Bullboard Posts
Next >>